CardioGraphe
Cardiac imaging solution component
Company profile
Company profile
Arineta is an innovative Israeli medical imaging company dedicated to advancing cardiovascular and thoracic imaging solutions through cutting-edge technology. Founded in late 2006 by Dr. Ehud Dafni and Mr. Yosi Morik, the company is located in the Caesarea Industrial Park, Israel, and benefits from a rich tradition of medical imaging innovation dating back to the 1970s. Arineta's flagship product, SpotLight™ Duo, is the world's first dedicated single-heartbeat, whole heart Cardiovascular and Thoracic CT scanner, incorporating the company's proprietary Stereo CT technology. The scanner features 140mm whole heart coverage with 560 slices, 0.24 second rotation speed providing 120msec temporal resolution, 0.28mm spatial resolution, and 139kW effective power. The company's mission is to grow cardiac CT as the front-line non-invasive test for diagnosing, therapy planning, and monitoring of cardiovascular disease. Arineta's team comprises highly skilled scientists, engineers, and business executives with impressive track records in developing and commercializing state-of-the-art medical devices. Among the company's scientists are the inventors of multi-slice spiral CT technology, which remains a cornerstone of CT imaging today. The company offers innovative deployment models including Pay Per Use financing and Mobile SpotLight solutions to improve access to cardiac CT in office cardiology practices, hospitals, radiology departments, and rural settings.
Company description Arineta official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
On Premise · Other deployment with recorded integration context.
Company milestones
Secured EU MDR CE Mark for SpotLight and SpotLight Duo (March 2026). Appointed Einav Ehre as Interim CEO (February 2026). Expanding focus on rural health systems and cardiac imaging access.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Cardiac imaging solution component
Mobile cardiovascular CT solution for community and rural settings
Flexible financing program for cardiac CT scanner acquisition
Dedicated cardiovascular CT scanner with Stereo CT technology
World's first dedicated single-heartbeat, whole heart cardiovascular and thoracic CT scanner
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Diagnostics (Basel, Switzerland) · Feb 20, 2023
Clinical validation
NCT02616939 · Sponsor · UNKNOWN
Regulatory
K250650 · 510k · Apr 15, 2025
SpotLight/SpotLight Duo with Low Dose Lung Cancer Screening OptionK241200 · 510k · Jan 13, 2025
SpotLight/SpotLight Duo (with DLIR option)K230370 · 510k · Oct 13, 2023
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Primary mission outcome
Core value proposition
Economic benefit claim
Cardiovascular CT imaging implementation
Cardiovascular CT imaging implementation
Cardiovascular CT imaging implementation
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Arineta's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.